Cell-seeded porous lung hydrogel sealant
US-2019224364-A1 · Jul 25, 2019 · US
US9387275B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9387275-B2 |
| Application number | US-25522408-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 21, 2008 |
| Priority date | Oct 22, 2007 |
| Publication date | Jul 12, 2016 |
| Grant date | Jul 12, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
One-component bone cement pastes, containing: AI at least one methacrylate monomer suitable for radical polymerization; AII at least one polymer that is soluble in AI; AIII at least one particulate polymer that is insoluble in AI and has a particle size of less than 500 μm; optionally AIV at least one radical-forming initiator or at least one radical initiator that is soluble in AI and subject to thermal decomposition; optionally AV at least one electrically conductive radio-opaquer, in the form of ferromagnetic particles.
Opening claim text (preview).
The invention claimed is: 1. A one-component polymethylmethacrylate bone cement paste consisting of (i) at least one methacrylate monomer selected from the group consisting of butan-1,3-diol-dimethacrylate, butan-1,4-diol-dimethacrylate, and hexan-1,6-diol-dimethacrylate; (ii) at least one polymer that is soluble in the methacrylate monomer; (iii) at least one particulate polymer selected from the group consisting of cross-linked poly-methylmethacrylate and cross-linked poly-methylmethacrylate-co-methylacrylate, wherein the particulate polymer is insoluble in the methacrylate monomer and having a particle size of less than 500 μm; (iv) at least one radical initiator that is soluble in the methacrylate monomer and subject to thermal decomposition; (v) at least one electrically conductive radio-opaquer; (vi) optionally at least one additional radio-opaquer; (vii) optionally at least one pharmaceutical agent; and (viii) optionally at least one biocompatible elastomer that is particulate or soluble in the methacrylate monomer/methacrylate monomers; wherein the ratio of said at least one methacrylate monomer to soluble polymer to particulate insoluble polymer to radical initiator to electrically conductive radio-opaquer is 25-50:2-35:40-70:0.5-4.0:2.0-20 based on the weight of the paste. 2. Bone cement paste according to claim 1 , wherein said at least one radical initiator that is soluble in the methacrylate monomer and subject to thermal decomposition can be activated. 3. Bone cement paste according to claim 1 , wherein said electrically conductive radio-opaquer is present and are particles having a particle size of 0.5 to 500 μm of cobalt, iron, NdFeB, SmCo, cobalt-chromium steel, zirconium, hafnium, titanium, titanium-aluminum-silicon alloys, or titanium-niobium alloys. 4. Bone cement paste according to claim 3 , wherein said electrical conductive radio-opaquer is iron in the form of ferromagnetic particles. 5. Bone cement paste according to claim 1 , wherein the methacrylate monomer is suited for distillation. 6. Bone cement paste according to claim 1 , wherein the soluble polymer is a poly-methylmethacrylate-co-polymer. 7. Bone cement paste according to claim 6 , wherein the soluble polymer is poly-methylmethacrylate-co-methylacrylate or poly-methyl methacrylate-co-styrene. 8. Bone cement paste according to claim 1 , wherein said at least one additional radio-opaquer is present and is selected from the group consisting of zirconium dioxide, barium sulfate, tantalum, and biocompatible calcium salts. 9. Bone cement paste according to claim 1 , wherein said at least one pharmaceutical agent is present and is selected from the group consisting of antibiotics, hormones, growth factors, and antiphlogistics. 10. Bone cement paste according to claim 1 , wherein said at least one biocompatible elastomer that is particulate or soluble in the methacrylate monomer is present. 11. Bone cement paste according to claim 10 , wherein said biocompatible elastomer is polybutadiene or poly-butadiene-co-styrene. 12. Method for curing a bone cement paste comprising exposing a bone cement paste according to claim 1 to an alternating magnetic field with a frequency in the range of 500 Hz to 50 kHz. 13. Method for curing a bone cement paste comprising heating a bone cement paste according to claim 2 by induction until the decomposition of the initiator commences.
containing macromolecular fillers · CPC title
Homopolymers or copolymers of methacrylic acid esters · CPC title
for reconstruction of bones; weight-bearing implants · CPC title
containing inorganic fillers not covered by groups A61L24/0078 or A61L24/0084 · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.